Tokyo, Feb. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060602) titled 'A systematic review of the efficacy of "delphinidin 3,5-diglucoside" on dry eyes effect in healthy adults. (update version)' on Feb. 6.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to clarify the functional effects of delphinidin 3,5-diglucoside intake on dry eyes effect in healthy adults, including reports of the latest clinical research. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - P-Participant: Participant The subjects were healthy adults (those who are not suffering from any diseases, excluding those under 18 years old, pregnant women, and lactating women)

I-intervention: Intervention (food) characteristics Continuous intake of delphinidin 3,5-diglucoside, Unlimited dosage forms, period and follow-up period.

C-Comparison: Comparison Placebo (The placebo's formulation is not specified)

O-Outcome: Outcome The primary outcome: Tear secretion (Schirmer's test) The secondary outcome: Subjective symptoms (VAS, DEQS), Other eye-related indicators (pupillary response, tear break-up time, Flicker test)

S-Study design: Study design Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials or open trial Key exclusion criteria - The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 02 Month 03 Day Anticipated trial start date - 2026 Year 02 Month 07 Day Last follow-up date - 2026 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069319

Disclaimer: Curated by HT Syndication.